Mathew Blackman
Stock Analyst at Stifel
(3.37)
# 998
Out of 5,090 analysts
61
Total ratings
58.14%
Success rate
14.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $6.94 | +0.86% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $20.92 | +48.18% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $300.66 | +5.77% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $13.54 | +84.64% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $29.38 | -14.91% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $304.49 | -3.77% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $91.10 | +3.18% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $15.90 | +50.94% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $2.06 | +45.63% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $65.49 | +52.70% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $21.45 | -25.41% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.42 | +16.77% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $6.94
Upside: +0.86%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $20.92
Upside: +48.18%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $300.66
Upside: +5.77%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $13.54
Upside: +84.64%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $29.38
Upside: -14.91%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $304.49
Upside: -3.77%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $91.10
Upside: +3.18%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $15.90
Upside: +50.94%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $2.06
Upside: +45.63%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $65.49
Upside: +52.70%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $21.45
Upside: -25.41%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.42
Upside: +16.77%